Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Clinical trial NCT06681220 · RECRUITING

Trial details

NCT number: NCT06681220
Sponsor: VA Office of Research and Development
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Small Cell Lung Cancer Recurrent Small Cell Lung Cancer

Start date: 2026-02-23
Primary completion: 2029-12-31
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.